BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 17932962)

  • 21. Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance.
    Mostofsky SH; Mazzocco MM; Aakalu G; Warsofsky IS; Denckla MB; Reiss AL
    Neurology; 1998 Jan; 50(1):121-30. PubMed ID: 9443468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A neurodevelopmental perspective on the acquisition of nonverbal cognitive skills in adolescents with fragile X syndrome.
    Kover ST; Pierpont EI; Kim JS; Brown WT; Abbeduto L
    Dev Neuropsychol; 2013; 38(7):445-60. PubMed ID: 24138215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
    Frankland PW; Wang Y; Rosner B; Shimizu T; Balleine BW; Dykens EM; Ornitz EM; Silva AJ
    Mol Psychiatry; 2004 Apr; 9(4):417-25. PubMed ID: 14981523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in Pakistan.
    Fatima T; Zaidi SA; Sarfraz N; Perween S; Khurshid F; Imtiaz F
    Am J Med Genet A; 2014 May; 164A(5):1151-61. PubMed ID: 24478267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of reduced expression of fragile X mental retardation protein in neurons and increased expression in astrocytes in idiopathic and syndromic autism (duplications 15q11.2-q13).
    Wegiel J; Brown WT; La Fauci G; Adayev T; Kascsak R; Kascsak R; Flory M; Kaczmarski W; Kuchna I; Nowicki K; Martinez-Cerdeno V; Wisniewski T; Wegiel J
    Autism Res; 2018 Oct; 11(10):1316-1331. PubMed ID: 30107092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trajectories of early brain volume development in fragile X syndrome and autism.
    Hazlett HC; Poe MD; Lightbody AA; Styner M; MacFall JR; Reiss AL; Piven J
    J Am Acad Child Adolesc Psychiatry; 2012 Sep; 51(9):921-33. PubMed ID: 22917205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amygdala dysfunction in men with the fragile X premutation.
    Hessl D; Rivera S; Koldewyn K; Cordeiro L; Adams J; Tassone F; Hagerman PJ; Hagerman RJ
    Brain; 2007 Feb; 130(Pt 2):404-16. PubMed ID: 17166860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered neural activity of magnitude estimation processing in adults with the fragile X premutation.
    Kim SY; Hashimoto R; Tassone F; Simon TJ; Rivera SM
    J Psychiatr Res; 2013 Dec; 47(12):1909-16. PubMed ID: 24045061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unstable mutations in the FMR1 gene and the phenotypes.
    Loesch D; Hagerman R
    Adv Exp Med Biol; 2012; 769():78-114. PubMed ID: 23560306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Age-dependent cognitive changes in carriers of the fragile X syndrome.
    Cornish KM; Li L; Kogan CS; Jacquemont S; Turk J; Dalton A; Hagerman RJ; Hagerman PJ
    Cortex; 2008 Jun; 44(6):628-36. PubMed ID: 18472033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tremor/ataxia syndrome related to Fragile X premutation].
    Sallansonnet-Froment M; De Greslan T; Roux X; Bounolleau P; Ouologuem M; Taillia H; Ricard D; Renard JL
    Presse Med; 2010 Feb; 39(2):187-95. PubMed ID: 19419833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intellectual functioning and behavioural features associated with mosaicism in fragile X syndrome.
    Baker EK; Arpone M; Vera SA; Bretherton L; Ure A; Kraan CM; Bui M; Ling L; Francis D; Hunter MF; Elliott J; Rogers C; Field MJ; Cohen J; Maria LS; Faundes V; Curotto B; Morales P; Trigo C; Salas I; Alliende AM; Amor DJ; Godler DE
    J Neurodev Disord; 2019 Dec; 11(1):41. PubMed ID: 31878865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fragile X syndrome: clinical presentation, pathology and treatment.
    Salcedo-Arellano MJ; Hagerman RJ; Martínez-Cerdeño V
    Gac Med Mex; 2020; 156(1):60-66. PubMed ID: 32026885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroanatomy of fragile X syndrome: the temporal lobe.
    Reiss AL; Lee J; Freund L
    Neurology; 1994 Jul; 44(7):1317-24. PubMed ID: 8035938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The neuroanatomy and neuroendocrinology of fragile X syndrome.
    Hessl D; Rivera SM; Reiss AL
    Ment Retard Dev Disabil Res Rev; 2004; 10(1):17-24. PubMed ID: 14994284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular and cellular aspects of mental retardation in the Fragile X syndrome: from gene mutation/s to spine dysmorphogenesis.
    De Rubeis S; Fernández E; Buzzi A; Di Marino D; Bagni C
    Adv Exp Med Biol; 2012; 970():517-51. PubMed ID: 22351071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare FMR1 gene mutations causing fragile X syndrome: A review.
    Sitzmann AF; Hagelstrom RT; Tassone F; Hagerman RJ; Butler MG
    Am J Med Genet A; 2018 Jan; 176(1):11-18. PubMed ID: 29178241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies.
    Lightbody AA; Reiss AL
    Dev Disabil Res Rev; 2009; 15(4):343-52. PubMed ID: 20014368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular and cognitive predictors of the continuum of autistic behaviours in fragile X.
    Loesch DZ; Bui QM; Dissanayake C; Clifford S; Gould E; Bulhak-Paterson D; Tassone F; Taylor AK; Hessl D; Hagerman R; Huggins RM
    Neurosci Biobehav Rev; 2007; 31(3):315-26. PubMed ID: 17097142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.